Related Experiment Video
Updated: Feb 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans
Kimberly Harding1, Tesfaye B Mersha, Joseph A Vassalotti
1Monarch Innovation Partners, Inc., Rockville, MD, USA.
Insights
African Americans experience significant disparities in chronic kidney disease (CKD) outcomes. Addressing genetic, social, and healthcare factors is crucial for improving CKD care and outcomes in this population.
Area of Science:
- Nephrology
- Public Health
- Health Disparities
Background:
- African Americans (AAs) face the most significant disparities in chronic kidney disease (CKD) outcomes compared to Caucasian Americans (CAs).
- CKD prevalence is 3.5 times higher in AAs, with disparities evident across all disease stages.
- AAs are 10 times more likely to develop hypertension-related kidney failure and 3 times more likely to progress to kidney failure than CAs.
Purpose of the Study:
- To highlight the critical disparities in CKD outcomes between African Americans and Caucasian Americans.
- To identify contributing factors to these health inequities.
- To propose evidence-based strategies for improving CKD care and outcomes in African Americans.
Main Methods:
- Review of existing literature on health and healthcare disparities in CKD.
- Analysis of prevalence and progression data for CKD in African Americans versus Caucasian Americans.
- Identification of contributing factors including genetic, social, and healthcare system elements.
Main Results:
- Significant disparities in CKD prevalence and progression exist between AAs and CAs.
- Hypertension-related kidney failure risk is substantially higher in AAs.
- Multiple factors, including social determinants and healthcare access, contribute to these disparities.
Conclusions:
- Factors such as genetic predispositions, social determinants of health, delayed referrals, fragmented care, and low clinical trial participation exacerbate CKD disparities.
- Implementing evidence-based approaches, including assessment tools for social determinants, enhanced outreach, improved medication adherence strategies, advanced pharmacological treatments, health IT integration, and patient engagement programs, is vital.
- These interventions hold the potential to positively impact CKD outcomes and reduce disparities among African Americans.
Background:
African Americans (AAs) suffer the widest gaps in chronic kidney disease (CKD) outcomes compared to Caucasian Americans (CAs) and this is because of the disparities that exist in both health and healthcare. In fact, the prevalence of CKD is 3.5 times higher in AAs compared to CAs. The disparities exist at all stages of CKD. Importantly, AAs are 10 times more likely to develop hypertension-related kidney failure and 3 times more likely to progress to kidney failure compared to CAs.
Summary:
Several factors contribute to these disparities including genetic and social determinants, late referrals, poor care coordination, medication adherence, and low recruitment in clinical trials. Key Messages: The development and implementation of CKD-related evidence-based approaches, such as clinical and social determinant assessment tools for medical interventions, more widespread outreach programs, strategies to improve medication adherence, safe and effective pharmacological treatments to control or eliminate CKD, as well as the use of health information technology, and patient-engagement programs for improved CKD outcomes may help to positively impact these disparities among AAs.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations

